Skip to main content
PMC home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 1996 Jul-Sep;2(3):176–182. doi: 10.3201/eid0203.960303

Conjugate vaccines and the carriage of Haemophilus influenzae type b.

M L Barbour 1
PMCID: PMC2626802  PMID: 8903227

Abstract

Pharyngeal carriage of Haemophilus influenzae type b (Hib) is important in the transmission of Hib organisms, the pathogenesis of Hib disease, and the development of immunity to the bacterium. The remarkable success of current vaccination programs against Hib has been due in part to the effect of conjugate Hib vaccines in decreasing carriage of Hib. This review explores evidence for this effect, and discusses the possible mechanisms of the mucosal influence of Hib conjugate vaccines.

Full Text

The Full Text of this article is available as a PDF (37.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbour M. L., Booy R., Crook D. W., Griffiths H., Chapel H. M., Moxon E. R., Mayon-White D. Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine. Pediatr Infect Dis J. 1993 Jun;12(6):478–484. doi: 10.1097/00006454-199306000-00005. [DOI] [PubMed] [Google Scholar]
  2. Barbour M. L., Crook D. W., Mayon-White R. T. An improved antiserum agar method for detecting carriage of Haemophilus influenzae type b. Eur J Clin Microbiol Infect Dis. 1993 Mar;12(3):215–217. doi: 10.1007/BF01967116. [DOI] [PubMed] [Google Scholar]
  3. Barbour M. L., Mayon-White R. T., Coles C., Crook D. W., Moxon E. R. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis. 1995 Jan;171(1):93–98. doi: 10.1093/infdis/171.1.93. [DOI] [PubMed] [Google Scholar]
  4. Bijlmer H. A., Evans N. L., Campbell H., Van Alphen L., Greenwood B. M., Valkenburg H. A., Zanen H. C. Carriage of Haemophilus influenzae in healthy Gambian children. Trans R Soc Trop Med Hyg. 1989 Nov-Dec;83(6):831–835. doi: 10.1016/0035-9203(89)90345-3. [DOI] [PubMed] [Google Scholar]
  5. Black S. B., Shinefield H. R., Fireman B., Hiatt R., Polen M., Vittinghoff E. Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. Pediatr Infect Dis J. 1991 Feb;10(2):97–104. doi: 10.1097/00006454-199102000-00004. [DOI] [PubMed] [Google Scholar]
  6. Booy R., Hodgson S., Griffiths H., Chapel H. M., Moxon E. R. Antibody persistence after accelerated immunisation against Haemophilus influenzae type b. BMJ. 1993 Apr 10;306(6883):971–972. doi: 10.1136/bmj.306.6883.971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Booy R., Moxon E. R. Immunisation of infants against Haemophilus influenzae type b in the UK. Arch Dis Child. 1991 Oct;66(10):1251–1254. doi: 10.1136/adc.66.10.1251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Booy R., Moxon E. R., MacFarlane J. A., Mayon-White R. T., Slack M. P. Efficacy of Haemophilus influenzae type B conjugate vaccine in Oxford region. Lancet. 1992 Oct 3;340(8823):847–847. doi: 10.1016/0140-6736(92)92719-v. [DOI] [PubMed] [Google Scholar]
  9. Booy R., Taylor S. A., Dobson S. R., Isaacs D., Sleight G., Aitken S., Griffiths H., Chapel H., Mayon-White R. T., Macfarlane J. A. Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule. Arch Dis Child. 1992 Apr;67(4):475–478. doi: 10.1136/adc.67.4.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bradshaw M. W., Schneerson R., Parke J. C., Jr, Robbins J. B. Bacterial antigens cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b. Lancet. 1971 May 29;1(7709):1095–1096. doi: 10.1016/s0140-6736(71)91837-x. [DOI] [PubMed] [Google Scholar]
  11. Crisel R. M., Baker R. S., Dorman D. E. Capsular polymer of Haemophilus influenzae, type b. I. Structural characterization of the capsular polymer of strain Eagan. J Biol Chem. 1975 Jul 10;250(13):4926–4930. [PubMed] [Google Scholar]
  12. Eskola J., Käyhty H., Takala A. K., Peltola H., Rönnberg P. R., Kela E., Pekkanen E., McVerry P. H., Mäkelä P. H. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N Engl J Med. 1990 Nov 15;323(20):1381–1387. doi: 10.1056/NEJM199011153232004. [DOI] [PubMed] [Google Scholar]
  13. Forsgren J., Samuelson A., Lindberg A., Rynnel-Dagö B. Quantitative bacterial culture from adenoid lymphatic tissue with special reference to Haemophilus [corrected]. Acta Otolaryngol. 1993 Sep;113(5):668–672. doi: 10.3109/00016489309135882. [DOI] [PubMed] [Google Scholar]
  14. Glode M. P., Daum R. S., Boies E. G., Ballard T. L., Murray M., Granoff D. M. Effect of rifampin chemoprophylaxis on carriage eradication and new acquisition of Haemophilus influenzae type b in contacts. Pediatrics. 1985 Oct;76(4):537–542. [PubMed] [Google Scholar]
  15. Granoff D. M., Daum R. S. Spread of Haemophilus influenzae type b: recent epidemiologic and therapeutic considerations. J Pediatr. 1980 Nov;97(5):854–860. doi: 10.1016/s0022-3476(80)80288-5. [DOI] [PubMed] [Google Scholar]
  16. Granoff D. M., Lucas A. H. Laboratory correlates of protection against Haemophilus influenzae type b disease. Importance of assessment of antibody avidity and immunologic memory. Ann N Y Acad Sci. 1995 May 31;754:278–288. doi: 10.1111/j.1749-6632.1995.tb44461.x. [DOI] [PubMed] [Google Scholar]
  17. Greenwood B. M., Hassan-King M., Whittle H. C. Prevention of secondary cases of meningococcal disease in household contacts by vaccination. Br Med J. 1978 May 20;1(6123):1317–1319. doi: 10.1136/bmj.1.6123.1317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hall D. B., Lum M. K., Knutson L. R., Heyward W. L., Ward J. I. Pharyngeal carriage and acquisition of anticapsular antibody to Haemophilus influenzae type b in a high-risk population in southwestern Alaska. Am J Epidemiol. 1987 Dec;126(6):1190–1197. doi: 10.1093/oxfordjournals.aje.a114758. [DOI] [PubMed] [Google Scholar]
  19. Herva E., Luotonen J., Timonen M., Sibakov M., Karma P., Mäkelä P. H. The effect of polyvalent pneumococcal polysaccharide vaccine on nasopharyngeal and nasal carriage of Streptococcus pneumoniae. Scand J Infect Dis. 1980;12(2):97–100. doi: 10.3109/inf.1980.12.issue-2.04. [DOI] [PubMed] [Google Scholar]
  20. Howard A. J., Dunkin K. T., Millar G. W. Nasopharyngeal carriage and antibiotic resistance of Haemophilus influenzae in healthy children. Epidemiol Infect. 1988 Apr;100(2):193–203. doi: 10.1017/s0950268800067327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kauppi M., Eskola J., Käyhty H. Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines. Pediatr Infect Dis J. 1995 Apr;14(4):286–294. doi: 10.1097/00006454-199504000-00008. [DOI] [PubMed] [Google Scholar]
  22. Kauppi M., Saarinen L., Käyhty H. Anti-capsular polysaccharide antibodies reduce nasopharyngeal colonization by Haemophilus influenzae type b in infant rats. J Infect Dis. 1993 Feb;167(2):365–371. doi: 10.1093/infdis/167.2.365. [DOI] [PubMed] [Google Scholar]
  23. Koskela M. Antibody response of young children to parenteral vaccination with pneumococcal capsular polysaccharides: a comparison between antibody levels in serum and middle ear effusion. Pediatr Infect Dis. 1986 Jul-Aug;5(4):431–434. doi: 10.1097/00006454-198607000-00011. [DOI] [PubMed] [Google Scholar]
  24. Käyhty H., Peltola H., Karanko V., Mäkelä P. H. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis. 1983 Jun;147(6):1100–1100. doi: 10.1093/infdis/147.6.1100. [DOI] [PubMed] [Google Scholar]
  25. Li K. I., Dashefsky B., Wald E. R. Haemophilus influenzae type b colonization in household contacts of infected and colonized children enrolled in day care. Pediatrics. 1986 Jul;78(1):15–20. [PubMed] [Google Scholar]
  26. Li K. I., Wald E. R., Dashefsky B. Nasal colonization with Haemophilus and immunization status. Pediatr Infect Dis J. 1987 Mar;6(3):303–304. doi: 10.1097/00006454-198703000-00028. [DOI] [PubMed] [Google Scholar]
  27. Michaels R. H., Norden C. W. Pharyngeal colonization with Haemophilus influenzae type b: a longitudinal study of families with a child with meningitis or epiglottitis due to H. influenzae type b. J Infect Dis. 1977 Aug;136(2):222–228. doi: 10.1093/infdis/136.2.222. [DOI] [PubMed] [Google Scholar]
  28. Michaels R. H., Poziviak C. S., Stonebraker F. E., Norden C. W. Factors affecting pharyngeal Haemophilus influenzae type b colonization rates in children. J Clin Microbiol. 1976 Nov;4(5):413–417. doi: 10.1128/jcm.4.5.413-417.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Michaels R. H., Stonebraker F. E., Robbins J. B. Use of antiserum agar for detection of Haemophilus influenzae type b in the pharynx. Pediatr Res. 1975 May;9(5):513–516. doi: 10.1203/00006450-197505000-00010. [DOI] [PubMed] [Google Scholar]
  30. Mohle-Boetani J. C., Ajello G., Breneman E., Deaver K. A., Harvey C., Plikaytis B. D., Farley M. M., Stephens D. S., Wenger J. D. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Pediatr Infect Dis J. 1993 Jul;12(7):589–593. doi: 10.1097/00006454-199307000-00009. [DOI] [PubMed] [Google Scholar]
  31. Moxon E. R., Anderson P. Meningitis caused by Haemophilus influenzae in infant rats: protective immunity and antibody priming by gastrointestinal colonization with Escherichia coli. J Infect Dis. 1979 Oct;140(4):471–478. doi: 10.1093/infdis/140.4.471. [DOI] [PubMed] [Google Scholar]
  32. Moxon E. R., Kroll J. S. The role of bacterial polysaccharide capsules as virulence factors. Curr Top Microbiol Immunol. 1990;150:65–85. doi: 10.1007/978-3-642-74694-9_4. [DOI] [PubMed] [Google Scholar]
  33. Moxon E. R., Ostrow P. T. Haemophilus influenzae meningitis in infant rats: role of bacteremia in pathogenesis of age-dependent inflammatory responses in cerebrospinal fluid. J Infect Dis. 1977 Feb;135(2):303–307. doi: 10.1093/infdis/135.2.303. [DOI] [PubMed] [Google Scholar]
  34. Moxon E. R., Smith A. L., Averill D. R., Smith D. H. Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis. 1974 Feb;129(2):154–162. doi: 10.1093/infdis/129.2.154. [DOI] [PubMed] [Google Scholar]
  35. Moxon E. R., Vaughn K. A. The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants. J Infect Dis. 1981 Apr;143(4):517–524. doi: 10.1093/infdis/143.4.517. [DOI] [PubMed] [Google Scholar]
  36. Murphy T. V., Pastor P., Medley F., Osterholm M. T., Granoff D. M. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J Pediatr. 1993 Apr;122(4):517–523. doi: 10.1016/s0022-3476(05)83529-2. [DOI] [PubMed] [Google Scholar]
  37. Murphy T. V., White K. E., Pastor P., Gabriel L., Medley F., Granoff D. M., Osterholm M. T. Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination. JAMA. 1993 Jan 13;269(2):246–248. [PubMed] [Google Scholar]
  38. Peltola H., Kilpi T., Anttila M. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet. 1992 Sep 5;340(8819):592–594. doi: 10.1016/0140-6736(92)92117-x. [DOI] [PubMed] [Google Scholar]
  39. Peltola H., Käyhty H., Sivonen A., Mäkelä H. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics. 1977 Nov;60(5):730–737. [PubMed] [Google Scholar]
  40. Pichichero M. E., Insel R. A. Mucosal antibody response to parenteral vaccination with Haemophilus influenzae type b capsule. J Allergy Clin Immunol. 1983 Nov;72(5 Pt 1):481–486. doi: 10.1016/0091-6749(83)90585-7. [DOI] [PubMed] [Google Scholar]
  41. Pittman M. VARIATION AND TYPE SPECIFICITY IN THE BACTERIAL SPECIES HEMOPHILUS INFLUENZAE. J Exp Med. 1931 Mar 31;53(4):471–492. doi: 10.1084/jem.53.4.471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Rynnel-Dagö B. Polyclonal activation to immunoglobulin secretion in human adenoid lymphocytes induced by bacteria from nasopharynx in vitro. Clin Exp Immunol. 1978 Dec;34(3):402–410. [PMC free article] [PubMed] [Google Scholar]
  43. Santosham M., Reid R., Ambrosino D. M., Wolff M. C., Almeido-Hill J., Priehs C., Aspery K. M., Garrett S., Croll L., Foster S. Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin. N Engl J Med. 1987 Oct 8;317(15):923–929. doi: 10.1056/NEJM198710083171503. [DOI] [PubMed] [Google Scholar]
  44. Santosham M., Wolff M., Reid R., Hohenboken M., Bateman M., Goepp J., Cortese M., Sack D., Hill J., Newcomer W. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med. 1991 Jun 20;324(25):1767–1772. doi: 10.1056/NEJM199106203242503. [DOI] [PubMed] [Google Scholar]
  45. Stein K. E. Thymus-independent and thymus-dependent responses to polysaccharide antigens. J Infect Dis. 1992 Jun;165 (Suppl 1):S49–S52. doi: 10.1093/infdis/165-supplement_1-s49. [DOI] [PubMed] [Google Scholar]
  46. Takala A. K., Eskola J., Leinonen M., Käyhty H., Nissinen A., Pekkanen E., Mäkelä P. H. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis. 1991 Nov;164(5):982–986. doi: 10.1093/infdis/164.5.982. [DOI] [PubMed] [Google Scholar]
  47. Takala A. K., Santosham M., Almeido-Hill J., Wolff M., Newcomer W., Reid R., Käyhty H., Esko E., Mäkelä P. H. Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children. Pediatr Infect Dis J. 1993 Jul;12(7):593–599. doi: 10.1097/00006454-199307000-00010. [DOI] [PubMed] [Google Scholar]
  48. Ward J. I., Fraser D. W., Baraff L. J., Plikaytis B. D. Haemophilus influenzae meningitis. A national study of secondary spread in household contacts. N Engl J Med. 1979 Jul 19;301(3):122–126. doi: 10.1056/NEJM197907193010302. [DOI] [PubMed] [Google Scholar]
  49. Ward J. I., Gorman G., Phillips C., Fraser D. W. Hemophilus influenzae type b disease in a day-care center. Report of an outbreak. J Pediatr. 1978 May;92(5):713–717. doi: 10.1016/s0022-3476(78)80134-6. [DOI] [PubMed] [Google Scholar]
  50. Ward J., Brenneman G., Letson G. W., Heyward W. L. Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. The Alaska H. influenzae Vaccine Study Group. N Engl J Med. 1990 Nov 15;323(20):1393–1401. doi: 10.1056/NEJM199011153232006. [DOI] [PubMed] [Google Scholar]
  51. Weiser J. N. Relationship between colony morphology and the life cycle of Haemophilus influenzae: the contribution of lipopolysaccharide phase variation to pathogenesis. J Infect Dis. 1993 Sep;168(3):672–680. doi: 10.1093/infdis/168.3.672. [DOI] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES